The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
about
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The combination of estramustin ...... ic Cooperative Oncology Group.
@ast
The combination of estramustin ...... ic Cooperative Oncology Group.
@en
type
label
The combination of estramustin ...... ic Cooperative Oncology Group.
@ast
The combination of estramustin ...... ic Cooperative Oncology Group.
@en
prefLabel
The combination of estramustin ...... ic Cooperative Oncology Group.
@ast
The combination of estramustin ...... ic Cooperative Oncology Group.
@en
P2093
P1433
P1476
The combination of estramustin ...... ic Cooperative Oncology Group.
@en
P2093
A Anagnostopoulos
D Bafaloukos
G Aravantinos
G F Samelis
Hellenic Cooperative Oncology Group
P Kosmidis
P304
P356
10.1016/S0090-4295(03)00019-0
P407
P577
2003-06-01T00:00:00Z